Stockscreener 앱 받기
17.49
3.00%
0.51
시장 영업 전:
17.62
0.13
+0.74%
전일 마감가:
$16.98
열려 있는:
$17.16
하루 거래량:
6.62M
Relative Volume:
0.69
시가총액:
$9.03B
수익:
$11.32B
순이익/손실:
$-981.00M
주가수익비율:
-8.9545
EPS:
-1.9532
순현금흐름:
$714.00M
1주 성능:
-0.51%
1개월 성능:
+5.23%
6개월 성능:
-2.83%
1년 성능:
-43.07%
1일 변동 폭
$17.16
$17.57
1주일 범위
$16.48
$17.85
52주 변동 폭
$15.73
$32.68
박스터 인터내셔널 Stock (BAX) Company Profile
명칭
Baxter International Inc
전화
(224) 948-2000
주소
ONE BAXTER PARKWAY, DEERFIELD, IL
Compare BAX vs ISRG, BDX, MDLN, ALC, RMD
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
BAX
Baxter International Inc
|
17.49 | 9.03B | 11.32B | -981.00M | 714.00M | -1.9532 |
ISRG
Intuitive Surgical Inc
|
453.49 | 160.61B | 10.58B | 3.00B | 2.83B | 8.2437 |
BDX
Becton Dickinson Co
|
153.26 | 43.60B | 21.92B | 1.76B | 2.63B | 6.1223 |
MDLN
Medline Inc
|
41.86 | 35.40B | 29.14B | 1.07B | 1.52B | 1.1995 |
ALC
Alcon Inc
|
63.88 | 31.15B | 10.40B | 980.00M | 1.61B | 1.9749 |
RMD
Resmed Inc
|
206.89 | 30.01B | 5.54B | 1.52B | 1.74B | 10.37 |
박스터 인터내셔널 Stock (BAX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-10-31 | 다운그레이드 | Argus | Buy → Hold |
| 2025-08-04 | 다운그레이드 | Stifel | Buy → Hold |
| 2025-08-01 | 다운그레이드 | Goldman | Buy → Neutral |
| 2025-02-26 | 재개 | Goldman | Buy |
| 2025-02-24 | 업그레이드 | Argus | Hold → Buy |
| 2025-02-20 | 재개 | Barclays | Overweight |
| 2024-07-15 | 다운그레이드 | Morgan Stanley | Equal-Weight → Underweight |
| 2024-05-30 | 개시 | Goldman | Neutral |
| 2024-05-10 | 다운그레이드 | TD Cowen | Buy → Hold |
| 2023-05-30 | 재개 | Morgan Stanley | Equal-Weight |
| 2023-03-29 | 개시 | UBS | Neutral |
| 2023-01-06 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2023-01-05 | 다운그레이드 | Raymond James | Outperform → Mkt Perform |
| 2023-01-03 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2022-12-19 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2022-12-15 | 다운그레이드 | Deutsche Bank | Buy → Hold |
| 2022-12-12 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2022-10-18 | 개시 | Barclays | Overweight |
| 2022-10-12 | 개시 | Jefferies | Hold |
| 2022-06-24 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2022-04-04 | 다운그레이드 | Goldman | Neutral → Sell |
| 2022-03-02 | 재개 | BofA Securities | Buy |
| 2022-02-18 | 재확인 | KeyBanc Capital Markets | Overweight |
| 2022-02-18 | 재확인 | Morgan Stanley | Overweight |
| 2022-02-18 | 재확인 | Raymond James | Outperform |
| 2022-02-18 | 재확인 | Stifel | Buy |
| 2022-02-18 | 재확인 | UBS | Neutral |
| 2022-02-18 | 재확인 | Wells Fargo | Overweight |
| 2022-02-11 | 개시 | Goldman | Neutral |
| 2022-01-07 | 재개 | Citigroup | Buy |
| 2022-01-07 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2021-09-13 | 업그레이드 | Cowen | Market Perform → Outperform |
| 2021-09-03 | 업그레이드 | Barclays | Equal Weight → Overweight |
| 2021-05-25 | 개시 | Barclays | Equal Weight |
| 2021-01-29 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2021-01-06 | 다운그레이드 | UBS | Buy → Neutral |
| 2020-12-15 | 다운그레이드 | Goldman | Buy → Neutral |
| 2020-10-01 | 업그레이드 | Citigroup | Neutral → Buy |
| 2020-09-04 | 다운그레이드 | Argus | Buy → Hold |
| 2020-06-24 | 개시 | Oppenheimer | Outperform |
| 2020-03-19 | 업그레이드 | Stifel | Hold → Buy |
| 2020-03-18 | 업그레이드 | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2020-03-05 | 개시 | Citigroup | Neutral |
| 2020-02-13 | 개시 | Goldman | Buy |
| 2020-01-02 | 업그레이드 | Evercore ISI | In-line → Outperform |
| 2019-12-17 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2019-06-26 | 개시 | KeyBanc Capital Markets | Sector Weight |
| 2019-04-08 | 다운그레이드 | Evercore ISI | Outperform → In-line |
| 2019-01-02 | 업그레이드 | Citigroup | Neutral → Buy |
| 2019-01-02 | 업그레이드 | Morgan Stanley | Underweight → Overweight |
| 2018-11-02 | 업그레이드 | Argus | Hold → Buy |
| 2018-10-16 | 개시 | Barclays | Underweight |
| 2018-05-17 | 재개 | Piper Jaffray | Overweight |
| 2018-02-06 | 재확인 | Citigroup | Neutral |
| 2018-01-03 | 개시 | Evercore ISI | Outperform |
| 2018-01-03 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
모두보기
박스터 인터내셔널 주식(BAX)의 최신 뉴스
Infusion Therapy Market Is Going to Boom | Baxter International, B. Braun Melsungen AG, Fresenius Kabi AG - openPR.com
Baxter International Still Has A Path To Upside - Seeking Alpha
Baxter International Inc. stock outperforms competitors on strong trading day - MarketWatch
Director at Baxter (NYSE: BAX) receives 12,836 fully vested share award, now holds 37,076 - Stock Titan
Baxter (BAX) director Amy McBride receives 12,836-share fully vested stock grant - Stock Titan
Director at Baxter (NYSE: BAX) awarded 12,836 shares, holds 34,994 - Stock Titan
Baxter International (BAX) director awarded 12,836 fully vested shares - Stock Titan
Baxter (BAX) board chair David Brent Shafer receives 12,836-share stock grant - Stock Titan
Director Michael McDonnell of Baxter (NYSE: BAX) receives 12,836-share fully vested grant - Stock Titan
Director Jeffrey A. Craig receives 12,836 Baxter (BAX) shares in grant - Stock Titan
Baxter (NYSE: BAX) director awarded 12,836 fully vested shares in Form 4 - Stock Titan
MSN Money - MSN
Becton Dickinson at 13x Earnings: MedTech’s Most Mispriced Compounder - Investing.com
Baxter International Inc. stock rises Wednesday, still underperforms market - MarketWatch
FMR LLC reports 9.0% stake in Baxter International (BAX) — 46.3M shares - Stock Titan
Assessing Baxter International’s Valuation After Earnings Beat And Guidance Reaffirmation - simplywall.st
Pheochromocytoma Market to Reach USD 3.86 Billion by 2033 at 8.5% - openPR.com
The Adirondack Small Cap Fund's Baxter International Inc(BAX) Holding History - GuruFocus
Baxter International Stock Outlook: Is Wall Street Bullish or Bearish? - Barchart.com
Baxter International Inc. stock underperforms Monday when compared to competitors - MarketWatch
Baxter International Inc. (BAX) Stock Analysis: Exploring a 28.5% Potential Upside for Healthcare Investors - DirectorsTalk Interviews
Research Alert: CFRA Keeps Hold Rating On Shares Of Baxter International Inc. - Moomoo
Assessing Baxter International (BAX) Valuation After Earnings Beat And Reaffirmed Outlook - Yahoo Finance
Baxter International Inc. (NYSE:BAX) Given Consensus Rating of "Reduce" by Brokerages - MarketBeat
Baxter International (BAX) Is Down 5.2% After Q1 Loss But Turnaround Guidance ReaffirmedWhat's Changed - Yahoo Finance UK
Baxter Profit Plunges 35% As Tariffs, Costs Bite - Sahm
Baxter International (NYSE:BAX) Stock Price Expected to Rise, The Goldman Sachs Group Analyst Says - MarketBeat
Baxter International (NYSE:BAX) Given New $19.00 Price Target at Stifel Nicolaus - MarketBeat
Baxter International (NYSE:BAX) Stock Price Expected to Rise, Barclays Analyst Says - MarketBeat
Baxter International Inc. Q1 2026 Financial Results: Revenue, Earnings, and Key Financial Statements - Minichart
Baxter International Inc. stock underperforms Friday when compared to competitors - MarketWatch
symbol__ Stock Quote Price and Forecast - CNN
Baxter International Inc. (NYSE:BAX) to Issue Quarterly Dividend of $0.01 - MarketBeat
Barclays Adjusts Baxter International Price Target to $27 From $25 - marketscreener.com
Goldman Sachs Adjusts Baxter International Price Target to $19 From $17 - marketscreener.com
TD Cowen Adjusts Baxter International Price Target to $20 From $22 - marketscreener.com
Stifel Nicolaus Adjusts Baxter International Price Target to $19 From $20 - Moomoo
Baxter International Inc. (NYSE:BAX) Q1 2026 Earnings Call Transcript - Insider Monkey
What's Going On With Baxter International Stock Friday?Baxter International (NYSE:BAX) - Benzinga
Goldman Sachs Maintains Baxter International Inc(BAX.US) With Hold Rating, Cuts Target Price to $19 - Moomoo
Baxter International Inc (BAX) Q1 2026 Earnings Call Highlights: Navigating Challenges with Strategic Growth Initiatives - GuruFocus
Baxter International (BAX) Q4 EPS Loss Deepens And Tests Bullish Margin Recovery Narrative - simplywall.st
Baxter International (NYSE:BAX) Releases Earnings Results, Beats Expectations By $0.05 EPS - MarketBeat
Baxter International Inc. 2026 Q1ResultsEarnings Call Presentation (NYSE:BAX) 2026-04-30 - Seeking Alpha
Baxter International’s Earnings Call Signals Cautious Turnaround - TipRanks
Baxter beats quarterly estimates, monitors effect from Middle East conflict - marketscreener.com
Evercore Cuts Baxter (BAX) Price Target, Keeps Outperform Rating - Insider Monkey
Baxter International Inc | 10-Q: Q1 2026 Earnings Report - Moomoo
Baxter International Inc. Q1 2026 Earnings Call Summary - Yahoo Finance
Special items push Baxter (NYSE: BAX) to small Q1 2026 net loss - Stock Titan
TD Cowen Maintains Baxter International Inc(BAX.US) With Hold Rating, Raises Target Price to $20 - Moomoo
박스터 인터내셔널 (BAX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.02%
0.93%
자본화:
|
볼륨(24시간):